EMA Provides Update On Metformin Impurity Concerns
FDA Also Urged To Take Further Action To Test For Impurities
Executive Summary
The European Medicines Agency has provided an update on the presence of potentially carcinogenic nitrosamines in certain medicines, including metformin, underlining that work is continuing to prevent and manage impurities.